Cresco Labs (TSE:CL) has released an update.
Cresco Labs has initiated adult-use cannabis sales in Ohio, expanding its market reach in a state poised to become a $2 billion industry. With its Sunnyside dispensaries now serving both medical and recreational customers, Cresco Labs is set to capitalize on nearly three-quarters of Ohioans over 21 as potential consumers. The company plans further expansion with three additional dispensaries, subject to state approvals.
For further insights into TSE:CL stock, check out TipRanks’ Stock Analysis page.
